Ever heard of CECD? Most people haven’t. It stands for Clinical Endocannabinoid Deficiency, and it’s more important to healthcare than people realize.
CECD is a dysfunction of the human endocannabinoid system (ECS). The ECS is composed of two endocannabinoid receptors, Cannabinoid #1 (CB1) and Cannabinoid #2 (CB2), which also interact with a substance known as cannabidiol (CBD). Located throughout the body, CB1 receptors are concentrated in the brain and central nervous system, while CB2 receptors are more heavily associated with the organs and immune system.
Given the role that the ECS plays in neurogenesis, it’s easy to see how the endocannabinoid receptors can be used to impact psychosomatic issues caused by CECD. Psychosomatic problems are those in which mental issues are manifested as physical symptoms. One example of this is hypochondria, or illness anxiety disorder, which can be described as a chronic fear of being seriously unwell. In such cases, the anxiety is the real illness, with any physical symptoms being posterior to the ones in the mind. [Read more…]